FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors

2.

Measurable Residual Disease Predicts Real-World AML Relapse

3.

Oleanolic acid from grapes may increase chemotherapy effectiveness

4.

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

5.

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot